MDT vs. BMY
Compare and contrast key facts about Medtronic plc (MDT) and Bristol-Myers Squibb Company (BMY).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: MDT or BMY.
Correlation
The correlation between MDT and BMY is 0.32, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
MDT vs. BMY - Performance Comparison
Key characteristics
MDT:
0.33
BMY:
0.55
MDT:
0.58
BMY:
1.05
MDT:
1.08
BMY:
1.13
MDT:
0.18
BMY:
0.34
MDT:
1.19
BMY:
1.69
MDT:
5.57%
BMY:
9.70%
MDT:
20.05%
BMY:
29.88%
MDT:
-57.63%
BMY:
-70.62%
MDT:
-26.95%
BMY:
-21.60%
Fundamentals
MDT:
$112.72B
BMY:
$117.65B
MDT:
$3.28
BMY:
-$4.41
MDT:
1.51
BMY:
1.36
MDT:
$33.20B
BMY:
$36.44B
MDT:
$20.88B
BMY:
$23.27B
MDT:
$9.39B
BMY:
$11.69B
Returns By Period
In the year-to-date period, MDT achieves a 10.90% return, which is significantly higher than BMY's 3.36% return. Over the past 10 years, MDT has outperformed BMY with an annualized return of 3.87%, while BMY has yielded a comparatively lower 2.27% annualized return.
MDT
10.90%
-4.78%
1.80%
6.89%
3.31%
3.87%
BMY
3.36%
-2.73%
9.06%
16.35%
4.35%
2.27%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
MDT vs. BMY — Risk-Adjusted Performance Rank
MDT
BMY
MDT vs. BMY - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Medtronic plc (MDT) and Bristol-Myers Squibb Company (BMY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
MDT vs. BMY - Dividend Comparison
MDT's dividend yield for the trailing twelve months is around 3.19%, less than BMY's 5.26% yield.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
MDT Medtronic plc | 3.19% | 3.49% | 3.34% | 3.44% | 2.39% | 1.95% | 1.87% | 2.15% | 2.24% | 2.34% | 1.88% | 1.66% |
BMY Bristol-Myers Squibb Company | 4.22% | 4.24% | 4.44% | 3.00% | 2.36% | 3.69% | 2.55% | 3.08% | 2.55% | 1.95% | 2.17% | 2.46% |
Drawdowns
MDT vs. BMY - Drawdown Comparison
The maximum MDT drawdown since its inception was -57.63%, smaller than the maximum BMY drawdown of -70.62%. Use the drawdown chart below to compare losses from any high point for MDT and BMY. For additional features, visit the drawdowns tool.
Volatility
MDT vs. BMY - Volatility Comparison
The current volatility for Medtronic plc (MDT) is 5.08%, while Bristol-Myers Squibb Company (BMY) has a volatility of 8.38%. This indicates that MDT experiences smaller price fluctuations and is considered to be less risky than BMY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
MDT vs. BMY - Financials Comparison
This section allows you to compare key financial metrics between Medtronic plc and Bristol-Myers Squibb Company. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities